{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T08:47:59Z","timestamp":1762073279408,"version":"build-2065373602"},"reference-count":32,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T00:00:00Z","timestamp":1667779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Acne vulgaris is one of the most common dermatological disorders among adolescents and adults in the Kingdom of Saudi Arabia (KSA). Isotretinoin is a cost-effective way of treating severe acne patients compared to other methods used for severe forms of acne management. The present study investigated the knowledge of the use of isotretinoin and its side effects among female acne patients of the reproductive age group who were on isotretinoin. This study also assessed participants\u2019 awareness of the Saudi FDA-Pregnancy Prevention Program (SFDA-PPP). Materials and Methods: The present population-based cross-sectional survey was conducted among 768 participants using a standard and validated Arabic version questionnaire. We have applied logistic regression analysis to determine the predictors for awareness of SFDA-PPP. A Chi-square test was applied to identify the factors associated with knowledge related to isotretinoin. Results: Regarding the side effects of isotretinoin, participated female acne patients were most commonly aware of dry mouth and lips (84.5%), teratogenicity (68.2%), and headache (44.8%). Nearly 60% of the participants belonged to the low knowledge category. The present study participants\u2019 knowledge was significantly associated with education status (p = 0.007), occupation (p = 0.01), and those participants who were aware of SFDA-PPP (p = 0.001). Furthermore, we explored that only 37.5% were aware of the SFDA-PPP program implemented in Saudi Arabia. The awareness of SFDA-PPP was significantly higher among those participants belonging to health sectors (Adjusted OR (95% CI) = 1.39 (1.01\u20131.92), p = 0.049). Conclusion: The present survey explored inadequate knowledge among reproductive age group female acne patients regarding isotretinoin uses, precautions to be followed, and side effects, especially teratogenic effects. This survey findings suggest that improving female acne patients\u2019 knowledge of isotretinoin through health promotion activities is crucial, especially by giving them precise instructions about the teratogenic effects.<\/jats:p>","DOI":"10.3390\/medicina58111609","type":"journal-article","created":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T12:45:47Z","timestamp":1667911547000},"page":"1609","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Knowledge on the Use of Isotretinoin and Its Side Effects and Awareness towards Saudi FDA-Pregnancy Prevention Program among the Female Acne Patients: A Northern Saudi Study"],"prefix":"10.3390","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3780-0725","authenticated-orcid":false,"given":"Ziad Mansour","family":"Alshaalan","sequence":"first","affiliation":[{"name":"Division of Dermatology, Department of Internal Medicine, College of Medicine, Jouf University, Sakaka 72388, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,11,7]]},"reference":[{"key":"ref_1","unstructured":"WHO (2022, May 31). Recognizing Neglected Skin Diseases: WHO Publishes Pictorial Training Guide. Available online: https:\/\/www.who.int\/news\/item\/08-06-2018-recognizing-neglected-skin-diseases-who-publishes-pictorial-training-guide."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4103\/jdds.jdds_71_19","article-title":"Prevalence of acne vulgaris, its contributing factors, and treatment satisfaction among the saudi population in Riyadh, Saudi Arabia: A cross-sectional study","volume":"24","author":"Alanazi","year":"2020","journal-title":"J. Dermatol. Dermatol. Surg."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s42506-020-00056-9","article-title":"Acne vulgaris: Prevalence, severity, and impact on quality of life and self-esteem among Egyptian adolescents","volume":"95","author":"Tayel","year":"2020","journal-title":"J. Egypt. Public Health Assoc."},{"key":"ref_4","first-page":"504279","article-title":"Female gender and acne disease are jointly and independently associated with the risk of major depression and suicide: A national population-based study","volume":"2014","author":"Yang","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"7224","DOI":"10.19082\/7224","article-title":"Prevalence and psychological impact of Acne vulgaris among female secondary school students in Arar city, Saudi Arabia, in 2018","volume":"10","author":"Alanazi","year":"2018","journal-title":"Electron. Physician"},{"key":"ref_6","first-page":"475","article-title":"Acne Vulgaris: Diagnosis and Treatment","volume":"100","author":"Oge","year":"2019","journal-title":"Am. Fam. Physician"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1080\/17512433.2020.1796637","article-title":"The use of isotretinoin for acne\u2014An update on optimal dosing, surveillance, and adverse effects","volume":"13","author":"Bagatin","year":"2020","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4103\/jdds.jdds_2_19","article-title":"Knowledge and use of isotretinoin in Saudi female college students: Cross-sectional study","volume":"23","author":"Albadr","year":"2019","journal-title":"J. Dermatol. Dermatol. Surg."},{"key":"ref_9","first-page":"e12148","article-title":"Females\u2019 Knowledge and Use of Isotretinoin (Roaccutane) in the Western Region of Saudi Arabia","volume":"12","author":"Bakheet","year":"2020","journal-title":"Cureus"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e12483","DOI":"10.1111\/dth.12483","article-title":"Adverse effects of isotretinoin: A large, retrospective review","volume":"30","author":"Brzezinski","year":"2017","journal-title":"Dermatol. Ther."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/jamadermatol.2019.1388","article-title":"US Food and Drug Administration Reports of Pregnancy and Pregnancy-Related Adverse Events Associated with Isotretinoin","volume":"155","author":"Tkachenko","year":"2019","journal-title":"JAMA Dermatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"534","DOI":"10.3892\/etm.2021.9966","article-title":"Teratogenic effect of isotretinoin in both fertile females and males (Review)","volume":"21","author":"Draghici","year":"2021","journal-title":"Exp. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"107","DOI":"10.23736\/S0026-4946.16.04778-2","article-title":"Teratogenicity of systemic isotretinoin","volume":"70","author":"Holst","year":"2018","journal-title":"Minerva Pediatr."},{"key":"ref_14","unstructured":"SFDA (2022, June 01). Saudi Food and Drug Authority, Available online: https:\/\/www.sfda.gov.sa\/en."},{"key":"ref_15","unstructured":"USFDA (2022, October 26). iPLEDGE. Available online: https:\/\/ipledgeprogram.com\/#Main."},{"key":"ref_16","unstructured":"GOV.UK (2022, October 26). Oral Retinoid Medicines: Revised and Simplified Pregnancy Prevention Educational Materials for Healthcare Professionals and Women, Available online: https:\/\/www.gov.uk\/drug-safety-update\/oral-retinoid-medicines-revised-and-simplified-pregnancy-prevention-educational-materials-for-healthcare-professionals-and-women."},{"key":"ref_17","unstructured":"SFDA (2022, June 01). SFDA\u2014Isotretinoin Prescrbing Guidleines, Available online: https:\/\/www.sfda.gov.sa\/sites\/default\/files\/2020-11\/Isotretinoin-Prescribing-Guide.pdf."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jsps.2021.04.013","article-title":"Awareness of isotretinoin use and Saudi FDA pregnancy prevention program in Riyadh, Saudi Arabia: A cross-sectional study among female patients","volume":"29","author":"Ibrahim","year":"2021","journal-title":"Saudi Pharm. J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.abd.2020.09.001","article-title":"Consensus on the use of oral isotretinoin in dermatology\u2014Brazilian Society of Dermatology","volume":"95","author":"Bagatin","year":"2020","journal-title":"Bras Derm."},{"key":"ref_20","unstructured":"Pile, H.D., and Sadiq, N.M. (2022). Isotretinoin. StatPearls, StatPearls Publishing."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4161\/derm.1.3.9364","article-title":"The use of isotretinoin in acne","volume":"1","author":"Layton","year":"2009","journal-title":"Dermato-Endocrinol."},{"key":"ref_22","first-page":"107","article-title":"Assessment of knowledge, attitude, and practice in relation to use of isotretinoin among Al-Madinah population, Saudi Arabia","volume":"4","author":"Molla","year":"2020","journal-title":"Int. J. Med. Dev. Ctries."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2147\/CCID.S256302","article-title":"Proper Counseling and Dispensing of Isotretinoin Capsule Products by Community Pharmacists in UAE: A Simulated Patient Study","volume":"13","author":"Rashid","year":"2020","journal-title":"Clin. Cosmet. Investig. Derm."},{"key":"ref_24","first-page":"e13669","article-title":"Knowledge levels and concerns about oral isotretinoin treatment in the parents of adolescent acne patients","volume":"33","author":"Ergun","year":"2020","journal-title":"Dermatol. Ther."},{"key":"ref_25","first-page":"e12873","article-title":"Perceptions about oral isotretinoin treatment","volume":"32","author":"Demirdag","year":"2019","journal-title":"Dermatol. Ther."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1177\/2168479018807677","article-title":"Public Understanding and Awareness of Isotretinoin Use and Safety in Al Ahsa, Eastern Saudi Arabia","volume":"53","author":"Younis","year":"2019","journal-title":"Innov. Regul. Sci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"9443884","DOI":"10.1155\/2022\/9443884","article-title":"Patients\u2019 Knowledge and Information Needs about Isotretinoin Therapy Use in Jordan","volume":"2022","author":"Jarab","year":"2022","journal-title":"Int. J. Clin. Pract."},{"key":"ref_28","first-page":"2339","article-title":"Knowledge and awareness of acne patients about isotretinoin use and safety in dawadmi governorate, riyadh region, Saudi Arabia","volume":"12","author":"Imam","year":"2021","journal-title":"Syst. Rev. Pharm."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Saqib, A., Atif, M., Ikram, R., Riaz, F., Abubakar, M., and Scahill, S. (2018). Factors affecting patients\u2019 knowledge about dispensed medicines: A Qualitative study of healthcare professionals and patients in Pakistan. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0197482"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"35s","DOI":"10.1177\/0272989X10378700","article-title":"Patients\u2019 knowledge about 9 common health conditions: The DECISIONS survey","volume":"30","author":"Fagerlin","year":"2010","journal-title":"Med. Decis. Mak."},{"key":"ref_31","first-page":"47","article-title":"Concerns and awareness of acne patients about isotretinoin in qassim region of saudi arabia","volume":"4","year":"2010","journal-title":"Int. J. Health Sci."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e10661","DOI":"10.7717\/peerj.10661","article-title":"Knowledge and attitudes towards stem cells and the significance of their medical application among healthcare sciences students of Jouf University","volume":"9","author":"Almaeen","year":"2021","journal-title":"PeerJ"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/58\/11\/1609\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:11:59Z","timestamp":1760145119000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/58\/11\/1609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,7]]},"references-count":32,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["medicina58111609"],"URL":"https:\/\/doi.org\/10.3390\/medicina58111609","relation":{},"ISSN":["1648-9144"],"issn-type":[{"type":"electronic","value":"1648-9144"}],"subject":[],"published":{"date-parts":[[2022,11,7]]}}}